21-amino acid peptide targeting expanded CAG repeat RNA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

62,645 results for “21-amino acid peptide targeting expanded CAG repeat RNA”

Trials

View all 33331 →

Amino Acid Digestibility of Whey and Zein Proteins

40 participants · First posted Sep 12, 2017

Spoonable Bioavailability

12 participants · First posted Dec 13, 2024

cMet CAR RNA T Cells Targeting Breast Cancer

6 participants · First posted Apr 23, 2013

Drugs

View all 8780 →

Anti-miR-21 RNA-peptide analog(Bound)

Amino acid

Anti-MYCN Peptide-nucleic Acid

Organizations

View all 553 →

Shanghai Ajinomoto Amino Acid Co., Ltd.

China

Ionis Pharmaceuticals, Inc.

United States

AMINO GmbH

Germany

News

View all 19981 →

FDA Grants Orphan Drug Designation to CUHK's Novel Peptide Drug Candidate

Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias

Altamira Therapeutics Partners with Undisclosed Company to Advance Circular RNA Delivery Platform

Page 1 of 6265